Cancer touches the lives of hundreds of thousands of Australians every year—and the numbers are only growing. In 2000, around 88,000 people were diagnosed with…
Radiation Oncology is a medical specialty that, at its core, combines technology and medicine, creating opportunities for spectacular improvements and advances in a relatively short…
Helsinki, Finland – February 2025 – MVision AI announces the introduction of Dose+, a software medical device designed to assist radiation therapy professionals in treatment…
Helsinki, Finland – February 2025 – The Therapeutic Goods Administration (TGA) of Australia has granted market approval for MVision AI’s MR-based segmentation models included in…
Helsinki, December 2024 – MVision AI is proud to announce that our flagship product, Contour+, has successfully transitioned from the EU Medical Devices Directive (MDD)…
Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top…
Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI) brings tremendous potential, so…
Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received…
Navigating Discomfort Radiation therapy is a non-invasive and non-painful cancer treatment. However, some patients might experience mild discomfort during treatment sessions, determined by a variety…
Helsinki, Finland, October 11, 2024 – Baylor College of Medicine and MVision AI have entered into a strategic research and development agreement to drive innovation…